TRIB logo

Trinity Biotech (TRIB) Shareholders Equity

Annual Shareholders Equity

-$23.95 M
-$21.77 M-1000.60%

31 December 2023

TRIB Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

-$26.34 M
+$3.06 M+10.40%

30 September 2024

TRIB Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TRIB Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1000.6%-50.6%
3 y3 years-979.3%-3352.1%
5 y5 years-154.4%-167.7%

TRIB Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-7407.5%at low-266.5%+10.4%
5 y5 years-154.4%at low-167.7%+10.4%
alltimeall time-111.2%at low-112.3%+10.4%

Trinity Biotech Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
-$26.34 M(-10.4%)
June 2024
-
-$29.40 M(+28.6%)
Mar 2024
-
-$22.86 M(-4.6%)
Dec 2023
-$23.95 M(+1000.6%)
-$23.95 M(+37.0%)
Sept 2023
-
-$17.49 M(+53.7%)
June 2023
-
-$11.38 M(+72.0%)
Mar 2023
-
-$6.62 M(+204.1%)
Dec 2022
-$2.18 M(+582.1%)
-$2.18 M(-132.8%)
Sept 2022
-
$6.63 M(-58.1%)
June 2022
-
$15.82 M(-351.7%)
Mar 2022
-
-$6.29 M(+1870.2%)
Dec 2021
-$319.00 K(-85.6%)
-$319.00 K(-139.4%)
Sept 2021
-
$810.00 K(-263.3%)
June 2021
-
-$496.00 K(+290.6%)
Mar 2021
-
-$127.00 K(-94.3%)
Dec 2020
-$2.22 M(-147.1%)
-$2.22 M(-131.4%)
Sept 2020
-
$7.07 M(-1093.1%)
June 2020
-
-$712.00 K(-192.7%)
Mar 2020
-
$768.00 K(-83.7%)
Dec 2019
$4.71 M(-89.3%)
$4.71 M(-87.9%)
Sept 2019
-
$38.93 M(-0.4%)
June 2019
-
$39.07 M(-11.5%)
Mar 2019
-
$44.17 M(+0.3%)
Dec 2018
$44.05 M(-32.4%)
$44.05 M(-35.3%)
Sept 2018
-
$68.08 M(+2.1%)
June 2018
-
$66.69 M(+1.4%)
Mar 2018
-
$65.78 M(+0.9%)
Dec 2017
$65.20 M(-40.0%)
$65.20 M(-38.7%)
Sept 2017
-
$106.39 M(-0.4%)
June 2017
-
$106.87 M(-2.2%)
Mar 2017
-
$109.28 M(+0.5%)
Dec 2016
$108.73 M(-49.2%)
$108.73 M(-48.3%)
Sept 2016
-
$210.40 M(-0.1%)
June 2016
-
$210.66 M(-0.9%)
Mar 2016
-
$212.47 M(-0.7%)
Dec 2015
$213.89 M(+8.6%)
$213.89 M(+1.4%)
Sept 2015
-
$211.00 M(+2.9%)
June 2015
-
$205.06 M(+1.9%)
Mar 2015
-
$201.24 M(+2.2%)
Dec 2014
$196.97 M(+7.6%)
$196.97 M(+1.1%)
Sept 2014
-
$194.78 M(-0.7%)
June 2014
-
$196.11 M(+3.8%)
Mar 2014
-
$189.01 M(+3.3%)
Dec 2013
$183.01 M(+8.0%)
$183.01 M(+4.5%)
Sept 2013
-
$175.13 M(+0.2%)
June 2013
-
$174.82 M(+0.1%)
Mar 2013
-
$174.61 M(+3.1%)
Dec 2012
$169.38 M(+11.9%)
$169.38 M(+2.6%)
Sept 2012
-
$165.06 M(+3.4%)
June 2012
-
$159.68 M(+0.2%)
Mar 2012
-
$159.30 M(+5.3%)
Dec 2011
$151.33 M(+7.1%)
$151.33 M(+1.6%)
Sept 2011
-
$148.97 M(+1.3%)
June 2011
-
$147.09 M(+1.8%)
Mar 2011
-
$144.55 M(+2.3%)
DateAnnualQuarterly
Dec 2010
$141.29 M(+78.1%)
$141.29 M(+3.3%)
Sept 2010
-
$136.74 M(+3.1%)
June 2010
-
$132.69 M(+61.9%)
Mar 2010
-
$81.96 M(+3.3%)
Dec 2009
$79.34 M(+20.4%)
$79.34 M(+4.2%)
Sept 2009
-
$76.18 M(+5.6%)
June 2009
-
$72.12 M(+7.0%)
Mar 2009
-
$67.42 M(+2.3%)
Dec 2008
$65.91 M(-51.8%)
$65.91 M(-55.4%)
Sept 2008
-
$147.81 M(+0.3%)
June 2008
-
$147.30 M(+6.1%)
Mar 2008
-
$138.81 M(+1.4%)
Dec 2007
$136.84 M(-18.2%)
$136.84 M(-22.2%)
June 2007
-
$175.82 M(+1.9%)
Mar 2007
-
$172.51 M(+3.1%)
Dec 2006
$167.26 M(+25.2%)
$167.26 M(+2.6%)
Sept 2006
-
$163.07 M(+3.0%)
June 2006
-
$158.36 M(+16.9%)
Mar 2006
-
$135.47 M(+1.4%)
Dec 2005
$133.62 M(+15.1%)
$133.62 M(+1.3%)
Sept 2005
-
$131.90 M(+3.9%)
June 2005
-
$126.98 M(+3.6%)
Mar 2005
-
$122.62 M(+5.6%)
Dec 2004
$116.14 M(+44.7%)
$116.14 M(-0.4%)
Sept 2004
-
$116.59 M(+1.3%)
June 2004
-
$115.14 M(+8.8%)
Mar 2004
-
$105.83 M(+31.9%)
Dec 2003
$80.26 M(+28.3%)
$80.26 M(+10.0%)
Sept 2003
-
$72.99 M(+4.8%)
June 2003
-
$69.67 M(+6.2%)
Mar 2003
-
$65.61 M(+4.9%)
Dec 2002
$62.54 M(+11.2%)
$62.54 M(+3.9%)
Sept 2002
-
$60.18 M(+1.5%)
June 2002
-
$59.28 M(+2.5%)
Mar 2002
-
$57.83 M(+2.9%)
Dec 2001
$56.22 M(+2.7%)
$56.22 M(-3.5%)
Sept 2001
-
$58.27 M(+1.9%)
June 2001
-
$57.18 M(+1.9%)
Mar 2001
-
$56.11 M(+2.5%)
Dec 2000
$54.73 M(+138.4%)
$54.73 M(+12.1%)
Sept 2000
-
$48.83 M(+11.7%)
June 2000
-
$43.70 M(+47.8%)
Mar 2000
-
$29.56 M(+28.8%)
Dec 1999
$22.95 M(+57.2%)
$22.95 M(+25.4%)
Sept 1999
-
$18.30 M(+6.4%)
June 1999
-
$17.20 M(+10.3%)
Mar 1999
-
$15.60 M(+6.8%)
Dec 1998
$14.60 M(+105.6%)
$14.60 M(+2.1%)
Sept 1998
-
$14.30 M(+62.5%)
June 1998
-
$8.80 M(+23.9%)
Dec 1997
$7.10 M(-33.0%)
$7.10 M(-33.0%)
Dec 1996
$10.60 M(+41.3%)
$10.60 M(+41.3%)
Dec 1995
$7.50 M(+476.9%)
$7.50 M(+212.5%)
Dec 1994
$1.30 M(-45.8%)
-
Feb 1994
-
$2.40 M
Feb 1994
$2.40 M
-

FAQ

  • What is Trinity Biotech annual stockholders equity?
  • What is the all time high annual shareholders equity for Trinity Biotech?
  • What is Trinity Biotech annual shareholders equity year-on-year change?
  • What is Trinity Biotech quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Trinity Biotech?
  • What is Trinity Biotech quarterly shareholders equity year-on-year change?

What is Trinity Biotech annual stockholders equity?

The current annual shareholders equity of TRIB is -$23.95 M

What is the all time high annual shareholders equity for Trinity Biotech?

Trinity Biotech all-time high annual stockholders equity is $213.89 M

What is Trinity Biotech annual shareholders equity year-on-year change?

Over the past year, TRIB annual stockholders equity has changed by -$21.77 M (-1000.60%)

What is Trinity Biotech quarterly stockholders equity?

The current quarterly shareholders equity of TRIB is -$26.34 M

What is the all time high quarterly shareholders equity for Trinity Biotech?

Trinity Biotech all-time high quarterly stockholders equity is $213.89 M

What is Trinity Biotech quarterly shareholders equity year-on-year change?

Over the past year, TRIB quarterly stockholders equity has changed by -$8.86 M (-50.64%)